Body and Mind Provides Corporate Update

VANCOUVER, BC, Jan. 14, 2021 /CNW/ - Body.....»»

VANCOUVER, British Columbia, June 29, 2018 (GLO.....»»

VANCOUVER, BC, Dec. 16, 2020 /PRNewswire/ - Body and Mind Inc. (CSE:BAMM) (OTCQB:BMMJ).....»»

VANCOUVER, BC, Dec. 16, 2020 /CNW/ - Body and Mind Inc. (CSE:BAMM) (OTCQB:BMMJ) (the "Company" or "BaM"), a multi-state operator, is pleased to announce its financial results for the fiscal year ended July 31, 2020 and is provi.....»»

NEW YORK, March 30, 2020 /PRNewswire/ -- Mind Medic.....»»

U.S. stocks fell at the start of Wednesday's trade as investors eyed a stream of high-profile corporate earnings and also a Federal Reserve policy update later in the afternoon. The Dow Jo.....»»

Up until recently, much of the focus about one’s individual wellness has been on the body and mind. We work out, take walks, do yoga and meditation as a way to keep our bodies and minds healthy and in shape. But there is another dimens.....»»

VANCOUVER, BC, Dec. 16, 2020 /CNW/ - WELL Health Technologies Corp. (TSX:WELL) ("WELL" or the "Company"), a company focused on consolidating and moderniz.....»»

Oxford, Connecticut, May 15, 2020 (GLOBE NEWSWIRE) -- Nxt-ID, Inc. (NASDAQ: NXTD) (the "Company"), a provider of healthcare devices and services, announces results for the three months ended March 31, 2020. Financial .....»»

BOSTON, May 15, 2020 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (NASDAQ:P.....»»

VBL Therapeutics Announces First Quarter 2020 Financial Results and Provides Corporate Update.....»»

NEW YORK and VIENNA, Austria, May 14, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ:HOOK, ‘HOOKIPA')), a company developing a new class of immunotherapeutics t.....»»

VANCOUVER, British Columbia, May 14, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. ("Emerald") (TSXV:EMH, OTCQX:EMHTF) reported fin.....»»

New Drug Applications for Epsolay® and Twyneo® remain on track for the second quarter and second half 2020, respectively Completed a $23 million underwritten public offering in February with an additional $5 million investment from .....»»

aTyr Pharma Announces First Quarter 2020 Results and Provides Corporate Update on ATYR1923 Clinical Trials in Pulmonary Sarcoidosis and COVID-19.....»»

Opiant Pharmaceuticals Announces First Quarter 2020 Financial Results and Corporate Update.....»»

Oncocyte Provides Corporate Update And Reports First Quarter 2020 Financial Results.....»»

CymaBay Therapeutics shares more than doubled on Tuesday after the company announced its first-quarter results, along with a corporate update......»»

MADRID, Spain and CAMBRIDGE, Mass., May 11, 2020 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a public clinical-stage bio.....»»

Enrollment completed in the dose optimization part of the ongoing Phase 1b/2 clinical t.....»»